SAA1 deficiency alleviates cardiac remodeling by inhibiting NF‐κB /p38/ JNK and TGFβ /Smad pathways
The FASEB Journal · 2023-05 · 37 (5)
DOI: 10.1096/fj.202201506r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 06.04.2023. Verfasst von Yusha Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, 430071, Wuhan, China. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathies. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wuhan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Heart failure (HF) is the end stage of the progression of many cardiovascular diseases. Cardiac remodeling is the main pathophysiological process of cardiac function deterioration in HF patients. Inflammation is a key factor that stimulates cardiomyocyte hypertrophy, fibroblast proliferation, and transformation leading to myocardial remodeling, which severity is significantly related to the prognosis of patients. SAA1 (Serum amyloid A1) is a lipid‐binding protein that was an important regulator involved in inflammation, whose biological functions in the heart remain rarely known. In this research, we intended to test the role of SAA1 in SAA1‐deficient (SAA1 −/− ), and wild‐type mice were exposed to transverse aortic banding surgery to establish the model of cardiac remodeling. Besides, we assessed the functional effects of SAA1 on cardiac hypertrophy and fibrosis. The expression of SAA1 was increased in the mice transverse aortic banding model induced by pressure overload. After 8 weeks of transverse aortic banding, SAA1 −/− mice displayed a lower level of cardiac fibrosis than wild‐type mice, but did not significantly influence the cardiomyocyte hypertrophy. In addition, there was also no significant difference in cardiac fibrosis severity between wild‐type‐sham and knockout‐sham mice. These findings are the first to reveal SAA1 absence hinders cardiac fibrosis after 8 weeks of transverse aortic banding. Furthermore, SAA1 deficiency had no significant effect on cardiac fibrosis and hypertrophy in the sham group in this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, 430071, Wuhan, China.
- Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery, 430071, Wuhan, China.
- Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease, 430071, Wuhan, China.
- Department of Nephrology, Zhongnan Hospital of Wuhan University, 430071, Wuhan, China.
- Department of Urology, Renmin Hospital of Wuhan University, 430060, Wuhan, China.
- Department of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, 430072, Wuhan, China.
Förderung
- Wuhan University
- National Natural Science Foundation of China
Zitieren
APA
Xiao, Y., Ni, L., Shi, H., Yang, K., Yang, J., Zhao, J., Liu, J., & Luo, P. (2023). SAA1 deficiency alleviates cardiac remodeling by inhibiting NF‐κB /p38/ JNK and TGFβ /Smad pathways. The FASEB Journal, 37(5). https://doi.org/10.1096/fj.202201506r
Vancouver
Xiao Y, Ni L, Shi H, Yang K, Yang J, Zhao J, et al. SAA1 deficiency alleviates cardiac remodeling by inhibiting NF‐κB /p38/ JNK and TGFβ /Smad pathways. The FASEB Journal. 2023;37(5). doi:10.1096/fj.202201506r
BibTeX
@article{Xiao2023,
author = {Xiao, Yusha and Ni, Lihua and Shi, Hongjie and Yang, Kang and Yang, Jianguo and Zhao, Jinping and Liu, Jinping and Luo, Pengcheng},
title = {SAA1 deficiency alleviates cardiac remodeling by inhibiting NF‐κB /p38/ JNK and TGFβ /Smad pathways},
journal = {The FASEB Journal},
year = {2023},
volume = {37},
number = {5},
doi = {10.1096/fj.202201506r}
}
EUVIMED